Long intergenic non-protein coding RNA 2506 (LINC02506)

Long intergenic non-protein coding RNA 2506 (LINC02506) is a human long intergenic non-coding RNA (lincRNA) gene transcript, longer than 200 nucleotides and located in a non-protein-coding genomic region[1][3]. Like other lincRNAs, LINC02506 does not code for a traditional protein but may play diverse regulatory roles at the RNA level, including chromatin remodeling, transcriptional regulation, and stabilization of other RNAs[3]. Recent research also indicates that some lincRNAs, including LINC02506, may generate small peptides from non-canonical open reading frames (smORFs) and serve as sources of tumor-specific antigens, contributing to cancer immunology and potentially acting as prognostic biomarkers[4]. LINC02506 is classified as a regulatory RNA and not a direct therapeutic target such as a receptor, enzyme, transporter, or ion channel[1][3][4]. Note: - LINC02506 is not a therapeutic target in the classical sense (such as a receptor or enzyme), but it may have *regulatory* and *biomarker* roles in cancer. - There are no known drugs or small molecules directly targeting LINC02506. - If structured target data are required for classic drug discovery, this entry would typically not be classed as a therapeutic "target" but as a non-coding regulatory RNA biomarker[3][4].

Other names

LINC02506long intergenic non-coding RNA 2506